XML 98 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Information
12 Months Ended
Sep. 30, 2015
Segment Information  
Segment Information

19.    Segment Information

        We are organized by segments on a worldwide basis. We evaluate performance based on a number of factors; however, the primary measures of performance are the net sales and income or loss from operations (before corporate allocations) of each segment, as these are the key performance indicators that we review. Operating income or loss for each segment does not include the impact of any intercompany transfer pricing mark-up, corporate general and administrative expenses, interest expense and other miscellaneous income/expense items. Corporate general and administrative expenses include, but are not limited to, human resources, legal, finance, and various other corporate level activity related expenses. Such unallocated expenses remain within Corporate/Manufacturing.

        All of our products fall into one or more of these four segments:

 

 

 

           

•          

Consumer Products Group—This segment sells products worldwide under various brand names and third-party private labels. Our products are sold to the major mass merchandisers, club stores, drug store chains and supermarkets, as well as to online retailers, independent pharmacies, health food stores, the military and other retailers. 

           

•          

Holland & Barrett International—This segment operates 843 Holland & Barrett stores (including 744 company-owned stores in the UK and Ireland; and franchised stores in the following countries: 33 in China, 28 in Singapore, 16 in United Arab Emirates, 10 in Cyprus, five in Malta, four in Kuwait, two in Spain and one in Gibraltar). Holland & Barrett International also operated 161 De Tuinen stores (including cobranded stores) in the Netherlands (of which five were franchises), 18 Essenza stores in Belgium, and 49 GNC/MET-Rx stores in the UK. Holland & Barrett International operates Holland & Barrett retail websites in the UK, Ireland, the Netherlands and Belgium, as well as retail websites for De Tuinen in the Netherlands and the GNC/MET-Rx brands in the UK. The revenue generated by this segment consists of sales of its branded products and third-party products as well as franchise fees. We are in the process of rebranding or cobranding our De Tuinen and Essenza stores to leverage consumer awareness of our Holland & Barrett brand. We are also in the process of rebranding our GNC brand stores to MET-Rx. 

           

•          

Puritan's Pride—This segment generates revenue through the sale of its branded products and third-party products primarily through the internet and mail order catalogs under the Puritan's Pride tradename. Catalogs are strategically mailed to customers who order by mail, internet, or phone. 

           

•          

Vitamin World—This segment generates revenue through its 385 owned and operated Vitamin World stores selling proprietary brand and third-party products, as well as internet-based sales fromwww.vitaminworld.com.

        The following table represents key financial information of our business segments:

                                                                                                                                                                                    

 

 

Total Reportable Business Segments

 

 

 

 

 

 

 

Consumer
Products
Group

 

Holland &
Barrett
International

 

Puritan's
Pride

 

Vitamin
World

 

Total

 

Corporate /
Manufacturing

 

Consolidated

 

Fiscal 2015:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

1,883,164

 

$

885,872

 

$

248,982

 

$

208,106

 

$

3,226,124

 

$

 

$

3,226,124

 

Income (loss) from operations(1)(2)

 

 

186,348

 

 

185,984

 

 

26,107

 

 

(53,224

)

 

345,215

 

 

(126,514

)

 

218,701

 

Depreciation and amortization

 

 

36,057

 

 

22,279

 

 

11,423

 

 

3,776

 

 

73,535

 

 

61,871

 

 

135,406

 

Capital expenditures

 

 

1,469

 

 

55,227

 

 

1,771

 

 

4,588

 

 

63,055

 

 

52,405

 

 

115,460

 

Fiscal 2014:

 

 


 

 

 


 

 

 


 

 

 


 

 

 


 

 

 


 

 

 


 

 

Net sales

 

$

1,879,481

 

$

850,797

 

$

250,224

 

$

225,276

 

$

3,205,778

 

$

 

$

3,205,778

 

Income (loss) from operations(3)

 

 

177,069

 

 

191,207

 

 

(141,660

)

 

(26,975

)

 

199,641

 

 

(96,901

)

 

102,740

 

Depreciation and amortization

 

 

36,092

 

 

18,048

 

 

11,319

 

 

3,344

 

 

68,803

 

 

37,754

 

 

106,557

 

Capital expenditures

 

 

482

 

 

42,315

 

 

1,456

 

 

14,095

 

 

58,348

 

 

46,859

 

 

105,207

 

Fiscal 2013:

 

 


 

 

 


 

 

 


 

 

 


 

 

 


 

 

 


 

 

 


 

 

Net sales

 

$

1,938,921

 

$

743,861

 

$

246,731

 

$

233,528

 

$

3,163,041

 

$

 

$

3,163,041

 

Income (loss) from operations(4)

 

 

231,812

 

 

170,479

 

 

39,104

 

 

24,538

 

 

465,933

 

 

(136,168

)

 

329,765

 

Depreciation and amortization

 

 

36,517

 

 

14,320

 

 

10,137

 

 

2,708

 

 

63,682

 

 

46,954

 

 

110,636

 

Capital expenditures

 

 

971

 

 

27,198

 

 

4,411

 

 

5,557

 

 

38,137

 

 

91,083

 

 

129,220

 


 

 

 

(1)          

Includes charges within Corporate / Manufacturing of $23,952 related to the sale of the nutritional bar assets and powder facility (see Note 4) and charges of $4,308 related to the Glucosamine settlement (see Note 11). Also includes charges in the Consumer Products Group and Puritan's Pride segments of $4,892 and $649, respectively, related to the write-off of goodwill in relation to the sale of the powder facility (see Note 7).

(2)          

Includes a charge within the Vitamin World segment of $55,000 related to the impairment on its indefinite-lived tradenames (see Note 7).

(3)          

Includes charges within the Puritan's Pride and Vitamin World segments of $171,590 and $35,744, respectively, related to the goodwill and intangible asset impairment charges (see Note 7).

(4)          

Includes charges within Corporate / Manufacturing of $32,695 relating to the facility restructuring (see Note 4) and $12,000 related to the accrual of the Glucosamine settlement (see Note 11).

        Total assets by segment as of September 30 are as follows:

                                                                                                                                                                                    

 

 

2015

 

2014

 

 

 

 

 

(As revised)

 

Reportable Business Segments:

 

 

 

 

 

 

 

Consumer Products Group

 

$

2,542,942 

 

$

2,504,402 

 

Holland & Barrett International

 

 

944,825 

 

 

948,010 

 

Puritan's Pride

 

 

514,795 

 

 

513,218 

 

Vitamin World

 

 

51,881 

 

 

109,962 

 

​  

​  

​  

​  

Total Reportable Business Segments:

 

 

4,054,443 

 

 

4,075,592 

 

​  

​  

​  

​  

Corporate / Manufacturing

 

 

813,966 

 

 

747,817 

 

​  

​  

​  

​  

Consolidated assets

 

$

4,868,409 

 

$

4,823,409 

 

​  

​  

​  

​  

​  

​  

​  

​  

        Assets by segment as of September 30, 2014 were revised to reflect the correction of the Company's policy with respect to its labels inventory and prepaid rent (as described in Note 2). This revision resulted in an increase in assets as follows: $3,743 for Consumer Products Group segment; $576 Puritan's Pride segment and $2,520 for Vitamin World segment, partially offset by a decrease of $2,552 for Corporate / Manufacturing.

        Total net sales by location of customer for the fiscal years ended September 30, are as follows:

                                                                                                                                                                                    

 

 

2015

 

2014

 

2013

 

United States

 

$

1,934,729 

 

$

1,934,668 

 

$

2,024,178 

 

United Kingdom

 

 

812,685 

 

 

767,173 

 

 

675,378 

 

Canada

 

 

116,296 

 

 

118,814 

 

 

129,476 

 

Netherlands

 

 

112,205 

 

 

116,107 

 

 

98,673 

 

Ireland

 

 

35,820 

 

 

40,235 

 

 

36,655 

 

Other foreign countries

 

 

214,389 

 

 

228,781 

 

 

198,681 

 

​  

​  

​  

​  

​  

​  

Consolidated net sales

 

$

3,226,124 

 

$

3,205,778 

 

$

3,163,041 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

        Long-lived assets—Property, plant and equipment as of September 30, are as follows:

                                                                                                                                                                                    

 

 

2015

 

2014

 

United States

 

$

387,376 

 

$

399,296 

 

United Kingdom

 

 

160,131 

 

 

146,814 

 

Netherlands

 

 

22,969 

 

 

15,778 

 

Ireland

 

 

8,937 

 

 

4,454 

 

Canada

 

 

6,419 

 

 

10,687 

 

Other foreign countries

 

 

19,876 

 

 

20,173 

 

​  

​  

​  

​  

Consolidated long-lived assets

 

$

605,708 

 

$

597,202 

 

​  

​  

​  

​  

​  

​  

​  

​  

        Approximately 36%, 35% and 32% of our net sales for the fiscal years ended September 30, 2015, 2014 and 2013, respectively, were denominated in currencies other than U.S. dollars, principally British pounds, euros, Renminbi and Canadian dollars. A significant weakening of such currencies versus the U.S. dollar could have a material adverse effect on the Company, as this would result in a decrease in our consolidated operating results.

        Foreign subsidiaries accounted for the following percentages of total assets and total liabilities as of September 30:

                                                                                                                                                                                    

 

 

2015

 

2014

 

Total Assets

 

 

29 

%

 

28 

%

Total Liabilities

 

 

%

 

%